March 25, 2026 - 01:51

POMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31, 2025. The company, which specializes in perinatal tissue allograft products, reported robust financial metrics for the period.
A key highlight from the report was the generation of $10.1 million in net revenue during the fourth quarter of 2025. The company achieved an exceptionally high gross margin of 97% for that quarter, underscoring the strength of its operational model and product portfolio.
Further solidifying its market position and growth trajectory, BioStem Technologies successfully completed a strategic acquisition. This move is anticipated to enhance the company's capabilities and expand its commercial reach within the regenerative medicine sector. The financial results reflect a period of significant execution and strategic advancement for the company as it continues to focus on developing and commercializing innovative biological solutions for wound care and tissue repair.
August 7, 2026 - 07:49
The ASX Stock Where Earnings Grows Faster Than Revenue, and WhyRevenue growth is good. Earnings growth is really good. Earnings growing faster than revenue, like this ASX stock, is even better. Archimedes once said, `Give me a lever and a place to stand, and I...
August 6, 2026 - 17:09
Zaria Aims to Bring National Trust Bank to Structured Finance MarketsZaria Systems, a technology firm focused on real-time infrastructure for mark-to-market credit and structured finance, is now setting its sights on obtaining a charter for a special-purpose...
August 6, 2026 - 04:42
How EVERTEC’s Profit Drop, Higher Guidance And Buybacks At EVERTEC (EVTC) Has Changed Its Investment StoryEVERTEC`s second quarter numbers tell a more complicated story than the headline profit decline suggests. Revenue climbed to 274.82 million dollars, a solid gain, but net income tumbled to just...
August 5, 2026 - 17:06
SpaceX stock hits new all-time low as AI capex jumps in Q2SpaceX delivered its inaugural quarterly report as a publicly traded company on Tuesday, posting numbers that beat Wall Street expectations on both revenue and profit. But the good news did little...